Filing Details

Accession Number:
0001209191-20-028481
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-12 16:12:25
Reporting Period:
2020-05-11
Accepted Time:
2020-05-12 16:12:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230482 W Jeffrey Sherman C/O Horizon Pharma Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-05-11 33,479 $4.96 47,445 No 4 M Direct
Ordinary Shares Disposition 2020-05-11 33,479 $45.00 13,966 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock option (right to buy) Disposition 2020-05-11 33,479 $0.00 33,479 $4.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-12-08 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 287,897 Indirect By Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020.
  2. The stock option is fully vested and exercisable.